{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:15Z","timestamp":1792276275727,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cmi.2025.11.034","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:54:00Z","timestamp":1764694440000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of fluoroquinolones and risk of seizures: a population-based cohort study"],"prefix":"10.1016","volume":"32","author":[{"given":"Paraskevi","family":"Tassopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Vivirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Douros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.11.034_bib1","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1503\/cmaj.160938","article-title":"Fluoroquinolone antimicrobial drugs","volume":"189","author":"Chan","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.cmi.2025.11.034_bib2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.clineuro.2012.03.029","article-title":"Levofloxacin neurotoxicity and non-convulsive status epilepticus (NCSE): a case report","volume":"114","author":"Mazzei","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.cmi.2025.11.034_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1186\/s12888-023-05425-0","article-title":"One case report of epilepsy and rapidly progressive cognitive impairment after levofloxacin treatment","volume":"23","author":"Su","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cmi.2025.11.034_bib4","unstructured":"U.S. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 2018. Accessed 20 Aug 2025. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side."},{"key":"10.1016\/j.cmi.2025.11.034_bib5","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1021\/acschemneuro.2c00200","article-title":"Stoichiometry-selective antagonism of \u03b14\u03b22 nicotinic acetylcholine receptors by fluoroquinolone antibiotics","volume":"13","author":"Sanders","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cmi.2025.11.034_bib6","series-title":"The NMDA receptor","article-title":"The NMDA receptor in epilepsy","author":"Clark","year":"1995"},{"key":"10.1016\/j.cmi.2025.11.034_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/31.4.457","article-title":"Antagonism of GABAA receptors by 4-quinolones","volume":"31","author":"Halliwell","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.11.034_bib8","doi-asserted-by":"crossref","first-page":"1435923","DOI":"10.3389\/fphar.2024.1435923","article-title":"Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database","volume":"15","author":"Xie","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cmi.2025.11.034_bib9","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/jac\/dkae255","article-title":"Fluoroquinolones and the risk for incidental seizures: a comparative retrospective study","volume":"79","author":"Gueta","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.11.034_bib10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1212\/WNL.0000000000002633","article-title":"Association between oral fluoroquinolones and seizures: a self-controlled case series study","volume":"86","author":"Chui","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2025.11.034_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.puhe.2022.02.013","article-title":"Sampling strategy, characteristics and representativeness of the InGef research database","volume":"206","author":"Ludwig","year":"2022","journal-title":"Public Health"},{"key":"10.1016\/j.cmi.2025.11.034_bib12","unstructured":"European Medicines Agency (EMA). Amoxil: Article 30 referral \u2014 Annex III. London: European Medicines Agency; 26 Jun 2015 (last updated 14 Sep 2015). Procedure No.: EMEA\/H\/A-30\/1372. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/amoxil-article-30-referral-annex-iii_en.pdf"},{"key":"10.1016\/j.cmi.2025.11.034_bib13","doi-asserted-by":"crossref","first-page":"106414","DOI":"10.1016\/j.eplepsyres.2020.106414","article-title":"Accuracy of ICD-10-CM claims-based definitions for epilepsy and seizure type","volume":"166","author":"Smith","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.cmi.2025.11.034_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","article-title":"Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians","volume":"55","author":"Gauthier","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2025.11.034_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.cmi.2025.11.034_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.bjp.0701411","article-title":"Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid","volume":"122","author":"Green","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cmi.2025.11.034_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.cmi.2025.11.034_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/EDE.0000000000000457","article-title":"Sensitivity analysis without assumptions","volume":"27","author":"Ding","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2025.11.034_bib19","unstructured":"Patel P.H., Hashmi M.F. Macrolides. StatPearls InternetInternetInternet. Treasure Island (FL): StatPearls Publishing; 2025 Jan. (Updated 2023 May 16). Copyright \u00a9 2025. StatPearls Publishing LLC; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551495\/"},{"key":"10.1016\/j.cmi.2025.11.034_bib20","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/AAC.37.9.1764","article-title":"Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice","volume":"37","author":"Akahane","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.11.034_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40261-017-0498-z","article-title":"Neuropsychiatric effects of antimicrobial agents","volume":"37","author":"Zareifopoulos","year":"2017","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.cmi.2025.11.034_bib22","doi-asserted-by":"crossref","first-page":"192ra85","DOI":"10.1126\/scitranslmed.3006055","article-title":"Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells","volume":"5","author":"Kalghatgi","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2025.11.034_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425255.2014.970166","article-title":"Safety issues and drug-drug interactions with commonly used quinolones","volume":"11","author":"Douros","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.cmi.2025.11.034_bib24","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2025.11.034_bib25","doi-asserted-by":"crossref","first-page":"k678","DOI":"10.1136\/bmj.k678","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study","volume":"360","author":"Pasternak","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2025.11.034_bib26","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/jamainternmed.2020.4199","article-title":"Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection","volume":"180","author":"Gopalakrishnan","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2025.11.034_bib27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pds.5083","article-title":"Time-related biases in pharmacoepidemiology","volume":"29","author":"Suissa","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25006068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25006068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:20:45Z","timestamp":1785363645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25006068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1198743X25006068"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.11.034","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of fluoroquinolones and risk of seizures: a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}